Yong Xin Selected Research

Yong Xin Research Topics

Disease

16	Neoplasms (Cancer) 12/2022 - 03/2011
6	Melanoma (Melanoma, Malignant) 02/2017 - 03/2011
4	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 02/2024 - 01/2018
3	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2022 - 01/2019
3	Diarrhea 03/2021 - 12/2016
2	Nasopharyngeal Carcinoma 04/2024 - 01/2012
2	Stomach Neoplasms (Stomach Cancer) 01/2023 - 01/2022
2	Prostatic Neoplasms (Prostate Cancer) 01/2022 - 11/2016
2	Carcinoma (Carcinomatosis) 01/2021 - 09/2014
2	Photosensitivity Disorders (Photodermatitis) 01/2021 - 01/2019
2	Lymphoma (Lymphomas) 01/2021 - 07/2017
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2019 - 07/2017
2	Vomiting 12/2018 - 04/2016
2	Skin Neoplasms (Skin Cancer) 07/2017 - 06/2017
2	Glioma (Gliomas) 11/2014 - 03/2011
1	Nasopharyngeal Neoplasms (Cancer of the Nasopharynx) 04/2024
1	Cardiac Arrhythmias (Arrythmia) 04/2024
1	Hypertension (High Blood Pressure) 04/2024
1	Pathologic Complete Response 01/2023
1	Inflammation (Inflammations) 12/2022
1	Esophageal Squamous Cell Carcinoma 01/2022
1	Squamous Cell Neoplasms (Squamous Cell Cancer) 01/2022
1	Infections 03/2021
1	Adenocarcinoma 03/2021
1	Proteinuria 03/2021
1	Adenocarcinoma of Lung 01/2021
1	B-Cell Lymphoma (Lymphoma, B Cell) 01/2021
1	Carcinogenesis 01/2020
1	Anorexia 12/2018
1	Squamous Cell Carcinoma of Head and Neck 12/2018
1	Dehydration (Water Stress) 12/2018
1	Hypokalemia 12/2018
1	Exanthema (Rash) 12/2018
1	Brain Neoplasms (Brain Tumor) 01/2018
1	Hypoxia (Hypoxemia) 11/2017
1	Neutropenia 12/2016
1	Breast Neoplasms (Breast Cancer) 12/2016
1	Cardiovascular Diseases (Cardiovascular Disease) 12/2016
1	Cutaneous Malignant Melanoma 04/2016
1	Nausea 04/2016

Drug/Important Bio-Agent (IBA)

5	Temozolomide (Temodar)FDA LinkGeneric 01/2018 - 03/2011
4	Photosensitizing Agents (Photosensitizers)IBA 01/2021 - 06/2017
3	ErbB Receptors (EGF Receptor)IBA 03/2021 - 12/2016
3	1-phenyl-3,3-dimethyltriazene (PDT)IBA 01/2021 - 01/2019
3	DNA (Deoxyribonucleic Acid)IBA 11/2016 - 10/2014
3	Alkylating AgentsIBA 11/2014 - 03/2011
2	Angiogenesis InhibitorsIBA 04/2024 - 03/2021
2	MicroRNAs (MicroRNA)IBA 01/2021 - 01/2020
2	Circular RNAIBA 01/2021 - 01/2020
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2021 - 11/2017
2	Vitamin K 3 (Menadione)FDA Link 01/2021 - 01/2019
2	Cytochromes c (Cytochrome c)IBA 01/2021 - 07/2017
2	Proteins (Proteins, Gene)FDA Link 07/2017 - 09/2014
2	demethoxycurcuminIBA 07/2017 - 06/2017
2	MethyltransferasesIBA 11/2014 - 10/2014
1	pazopanib FDA Link 04/2024
1	endostar proteinIBA 04/2024
1	apatinibIBA 04/2024
1	Bevacizumab (Avastin)FDA Link 04/2024
1	Sunitinib (Sutent)FDA Link 04/2024
1	anlotinibIBA 04/2024
1	Albumin-Bound Paclitaxel FDA Link 12/2022
1	Serum AlbuminIBA 12/2022
1	AndrogensIBA 01/2022
1	nimotuzumabIBA 01/2022
1	ProcalcitoninIBA 03/2021
1	Transforming Growth Factors (Transforming Growth Factor)IBA 03/2021
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 03/2021
1	Messenger RNA (mRNA)IBA 01/2021
1	Caspase 9IBA 01/2021
1	Hyaluronic Acid (Hyaluronan)IBA 01/2021
1	Caspase 3 (Caspase-3)IBA 01/2021
1	Oxygen (Dioxygen)IBA 01/2019
1	Monoclonal AntibodiesIBA 12/2018
1	Tyrosine Kinase InhibitorsIBA 12/2018
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 11/2017
1	Bisbenzimidazole (Hoechst 33258)IBA 07/2017
1	CurcuminIBA 06/2017
1	AminesIBA 02/2017
1	Nylons (Nylon)IBA 02/2017
1	Dendrimers (Dendrons)IBA 02/2017
1	RNA (Ribonucleic Acid)IBA 01/2017
1	Lapatinib (GW572016)FDA Link 12/2016
1	Trastuzumab (Herceptin)FDA Link 12/2016
1	human ERBB2 proteinIBA 12/2016
1	Hormones (Hormone)IBA 11/2016
1	Dacarbazine (DIC)FDA LinkGeneric 04/2016
1	InterferonsIBA 04/2016
1	O-(6)-methylguanineIBA 11/2014
1	DNA Repair EnzymesIBA 11/2014
1	EnzymesIBA 09/2014

Therapy/Procedure

14	Therapeutics 01/2022 - 07/2011
9	Radiotherapy 12/2022 - 01/2012
6	Drug Therapy (Chemotherapy) 01/2021 - 03/2011
4	Chemoradiotherapy 04/2024 - 01/2021
4	Neoadjuvant Therapy 01/2023 - 12/2016
4	Photochemotherapy (Photodynamic Therapy) 01/2021 - 06/2017
1	Immunotherapy 02/2024
1	Bronchoscopes 03/2021
1	RNAi Therapeutics 01/2017